跳至主要内容
临床试验/CTIS2023-508532-56-00
CTIS2023-508532-56-00进行中(未招募)1 期

ow INR to Minimize bleeding with mechanical valves Trial (LIMIT) - 2019.06.26

Hamilton Health Sciences Corporation0 个研究点目标入组 1,880 人开始时间: 2023年10月5日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
1,880

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 65+(—)
性别
All

入选标准

  • Have had a bileaflet mechanical heart valve implant in the aortic position at least 3 months ago (greater than or equal to 3 months), Be at least 18 years of age at the time of enrollment (greater than or equal to 18 years of age), Provide written informed consent (either from the patient or substitute decision-maker)

排除标准

  • Have a second implanted mechanical valve (any position), Lower boundary of planned INR range is less than 2.0, Pregnant or expecting to become pregnant during the study follow-up

研究者

相似试验